Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Drug Metabolism and Disposition
Date
2010-03-01
Source
Crossref
DOI
10.1124/dmd.109.031138
PubMed
20007669
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:50 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Indexed papers citing this DOI

Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs2026-03-18Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans2025-04-21Elucidating the Phase I metabolism of psilocin in vitro2025-03-01Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin2024-01-08Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybin2024-01-06A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines2023-09-09Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybin2022-06-01Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2021-02-01Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin2021-01-01Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance2017-01-02Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol2013-08-01Enzyme-assisted synthesis of the glucuronide conjugate of psilocin, an hallucinogenic component of magic mushrooms2011-09-01

Related papers

No close related records were found yet.